Nanotechnology-based drug delivery of ropinirole for Parkinson's disease
A new drug delivery system is developed for ropinirole (RP) for the treatment of Parkinson's disease (PD) consisting of biodegradable poly (D,L-lactide-co-glycolide) (PLGA) nanoparticles (NPs). The formulation selected was prepared with 8 mg RP and 50 mg PLGA 502. This formulation exhibited mea...
Saved in:
Main Authors: | Emilia Barcia (Author), Liudmila Boeva (Author), Luis García-García (Author), Karla Slowing (Author), Ana Fernández-Carballido (Author), Yaquelyn Casanova (Author), Sofía Negro (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Micro- and Nano-Systems Developed for Tolcapone in Parkinson's Disease
by: Yaquelyn Casanova, et al.
Published: (2022) -
Nanotechnology platforms in Parkinson's Disease
by: Rishi Rajat Adhikary, et al.
Published: (2015) -
Neuroprotective Effect of Ropinirole Lipid Nanoparticles Enriched Hydrogel for Parkinson's Disease: In Vitro, Ex Vivo, Pharmacokinetic and Pharmacodynamic Evaluation
by: Narendar Dudhipala, et al.
Published: (2020) -
Application of Nanotechnology in Drug Delivery
Published: (2014) -
Development and optimization of Ropinirole loaded self-nanoemulsifying tablets
by: Krunal Detholia, et al.
Published: (2023)